Maternal obesity, inflammation, and developmental programming

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Segovia, Stephanie A ^a   Vickers, Mark H ^a   Gray, Clint ^a   Reynolds, Clare M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CURCUMIN; DNA METHYLTRANSFERASE 3B; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; OMEGA 3 FATTY ACID; RESVERATROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TAURINE;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT DISEASE; ADULTHOOD; APPETITE; BODY MASS; CALORIC INTAKE; DEVELOPMENT; DEVELOPMENTAL PROGRAMMING; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FATTY ACID SYNTHESIS; FATTY LIVER; FETAL ORIGIN OF ADULT DISEASE; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAUTERINE GROWTH RETARDATION; MATERNAL NUTRITION; MATERNAL OBESITY; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; PREGNANCY; PREGNANT WOMAN; PROADIPOCYTE; PROGENY; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE; FEMALE; FETUS DEVELOPMENT; METABOLISM; OBESITY; ORGANOGENESIS; PATHOPHYSIOLOGY; PREGNANCY COMPLICATIONS; PREVALENCE;

ANTI-INFLAMMATORY AGENTS; FEMALE; FETAL DEVELOPMENT; HUMANS; INFLAMMATION; INSULIN RESISTANCE; OBESITY; ORGANOGENESIS; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE;

EID: 84902159878     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/418975     Document Type: Review

References (186)

1. Heslehurst N., Ells L. J., Simpson H., Batterham A., Wilkinson J., Summerbell C. D., Trends in maternal obesity incidence rates, demographic predictors, and health inequalities in 36,821 women over a 15-year period. BJOG 2007 114 2 187 194 2-s2.0-33846139695 10.1111/j.1471-0528.2006.01180.x (Pubitemid 46089447)
2. Heslehurst N., Sattar N., Rajasingam D., Wilkinson J., Summerbell C. D., Rankin J., Existing maternal obesity guidelines may increase inequalities between ethnic groups: a national epidemiological study of 502,474 births in England. BMC Pregnancy & Childbirth 2012 12 1, article 156
3. Flegal K. M., Carroll M. D., Ogden C. L., Curtin L. R., Prevalence and trends in obesity among US adults, 1999-2008. Journal of the American Medical Association 2010 303 3 235 241 2-s2.0-74549140993 10.1001/jama.2009.2014
4. Catalano P. M., Ehrenberg H. M., The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG 2006 113 10 1126 1133 2-s2.0-33748754174 10.1111/j.1471-0528.2006.00989.x (Pubitemid 44401205)
5. Alfaradhi M. Z., Ozanne S. E., Developmental programming in response to maternal overnutrition. Frontiers in Genetics 2011 2, article 27 10.3389/fgene.2011.00027
6. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485 (Pubitemid 46024993)
7. Basu S., Haghiac M., Surace P., Challier J.-C., Guerre-Millo M., Singh K., Waters T., Minium J., Presley L., Catalano P. M., Hauguel-De Mouzon S., Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity 2011 19 3 476 482 2-s2.0-79952006811 10.1038/oby.2010.215
8. Madan J. C., Davis J. M., Craig W. Y., Collins M., Allan W., Quinn R., Dammann O., Maternal obesity and markers of inflammation in pregnancy. Cytokine 2009 47 1 61 64 2-s2.0-67549110726 10.1016/j.cyto.2009.05.004
9. Challier J. C., Basu S., Bintein T., Minium J., Hotmire K., Catalano P. M., Hauguel-de Mouzon S., Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008 29 3 274 281 2-s2.0-40649100721 10.1016/j.placenta.2007.12.010
10. Yan X., Tong J. F., Zhu M. J., Ford S. P., Nathanielsz P. W., Du M., Maternal obesity induces inflammation and adipogenesis in late gestation fetal sheep muscle. Diabetes 2009 58 A85 A85
11. Barker D. J. P., In utero programming of chronic disease. Clinical Science 1998 95 2 115 128 2-s2.0-0031661215 10.1042/CS19980019 (Pubitemid 28401260)
12. Barker D. J. P., Osmond C., Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. The Lancet 1986 1 8489 1077 1081 2-s2.0-0022621648 (Pubitemid 16106274)
13. Barker D. J., The developmental origins of adult disease. Journal of the American College of Nutrition 2004 23 supplement 6 588S 595S 10.1080/07315724.2004.10719428 (Pubitemid 40096746)
14. de Boo H. A., Harding J. E., The developmental origins of adult disease (Barker) hypothesis. Australian and New Zealand Journal of Obstetrics and Gynaecology 2006 46 1 4 14 2-s2.0-33645079134 10.1111/j.1479-828X.2006.00506.x
15. Gluckman P. D., Hanson M. A., Beedle A. S., Early life events and their consequences for later disease: a life history and evolutionary perspective. American Journal of Human Biology 2007 19 1 1 19 2-s2.0-33846058958 10.1002/ajhb.20590 (Pubitemid 46062455)
16. Vickers M. H., Breier B. H., Cutfield W. S., Hofman P. L., Gluckman P. D., Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. American Journal of Physiology: Endocrinology and Metabolism 2000 279 1 E83 E87 2-s2.0-0033854908 (Pubitemid 30609948)
17. Whitaker R. C., Wright J. A., Pepe M. S., Seidel K. D., Dietz W. H., Predicting obesity in young adulthood from childhood and parental obesity. The New England Journal of Medicine 1997 337 13 869 873 10.1056/NEJM199709253371301 (Pubitemid 27408568)
18. Catalano P. M., Presley L., Minium J., Mouzon S. H.-D., Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 2009 32 6 1076 1080 2-s2.0-66549089201 10.2337/dc08-2077
19. Labayen I., Ruiz J. R., Ortega F. B., Loit H.-M., Harro J., Veidebaum T., Sjöström M., Intergenerational cardiovascular disease risk factors involve both maternal and paternal BMI. Diabetes Care 2010 33 4 894 900 2-s2.0-77953032698 10.2337/dc09-1878
20. Shankar K., Harrell A., Liu X., Gilchrist J. M., Ronis M. J. J., Badger T. M., Maternal obesity at conception programs obesity in the offspring. American Journal of Physiology: Regulatory Integrative and Comparative Physiology 2008 294 2 R528 R538 2-s2.0-38949161492 10.1152/ajpregu.00316.2007 (Pubitemid 351213759)
21. Samuelsson A.-M., Matthews P. A., Argenton M., Christie M. R., McConnell J. M., Jansen E. H. J. M., Piersma A. H., Ozanne S. E., Twinn D. F., Remacle C., Rowlerson A., Poston L., Taylor P. D., Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming. Hypertension 2008 51 2 383 392 2-s2.0-38549152262 10.1161/HYPERTENSIONAHA.107.101477 (Pubitemid 351159954)
22. Wang J., Ma H., Tong C., Zhang H., Lawlis G. B., Li Y., Zang M., Ren J., Nijland M. J., Ford S. P., Nathanielsz P. W., Li J., Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart. FASEB Journal 2010 24 6 2066 2076 2-s2.0-77953508427 10.1096/fj.09-142315
23. McCurdy C. E., Bishop J. M., Williams S. M., Grayson B. E., Smith M. S., Friedman J. E., Grove K. L., Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. Journal of Clinical Investigation 2009 119 2 323 335 2-s2.0-61749094289 10.1172/JCI32661
24. Zambrano E., Martínez-Samayoa P. M., Rodríguez- González G. L., Nathanielsz P. W., Dietary intervention prior to pregnancy reverses metabolic programming in male offspring of obese rats. Journal of Physiology 2010 588 part 10 1791 1799 2-s2.0-77954075953 10.1113/jphysiol.2010.190033
25. Bringhenti I., Schultz A., Rachid T., Bomfim M. A., Mandarim-de-Lacerda C. A., Aguila M. B., An early fish oil-enriched diet reverses biochemical, liver and adipose tissue alterations in male offspring from maternal protein restriction in mice. The Journal of Nutritional Biochemistry 2011 22 11 1009 1014 2-s2.0-80054087502 10.1016/j.jnutbio.2010.08.013
26. Gray C., Li M., Reynolds C. M., Vickers M. H., Pre-weaning growth hormone treatment reverses hypertension and endothelial dysfunction in adult male offspring of mothers undernourished during pregnancy. PLoS ONE 2013 8 1 e53505
27. Zhang Y., Scarpace P. J., The role of leptin in leptin resistance and obesity. Physiology and Behavior 2006 88 3 249 256 2-s2.0-33745197808 10.1016/j.physbeh.2006.05.038
28. Hendler I., Blackwell S. C., Mehta S. H., Whitty J. E., Russell E., Sorokin Y., Cotton D. B., The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. American Journal of Obstetrics and Gynecology 2005 193 3 979 983 2-s2.0-24644462266 10.1016/j.ajog.2005.06.041 (Pubitemid 41285480)
29. Vickers M. H., Gluckman P. D., Coveny A. H., Hofman P. L., Cutfield W. S., Gertler A., Breier B. H., Harris M., Neonatal leptin treatment reverses developmental programming. Endocrinology 2005 146 10 4211 4216 2-s2.0-24944471310 10.1210/en.2005-0581 (Pubitemid 41324016)
30. Reynolds C. M., Li M., Gray C., Vickers M. H., Pre-weaning growth hormone treatment ameliorates bone marrow macrophage inflammation in adult male rat offspring following maternal undernutrition. PLoS ONE 2013 8 7 e68262
31. Bagley H. N., Wang Y., Campbell M. S., Yu X., Lane R. H., Joss-Moore L. A., Maternal docosahexaenoic acid increases adiponectin and normalizes IUGR-induced changes in rat adipose deposition. Journal of Obesity 2013 2013 7 312153 10.1155/2013/312153
32. Lillycrop K. A., Phillips E. S., Jackson A. A., Hanson M. A., Burdge G. C., Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. Journal of Nutrition 2005 135 6 1382 1386 2-s2.0-20444411948 (Pubitemid 40799599)
33. Torrens C., Brawley L., Anthony F. W., Dance C. S., Dunn R., Jackson A. A., Poston L., Hanson M. A., Folate supplementation during pregnancy improves offspring cardiovascular dysfunction induced by protein restriction. Hypertension 2006 47 5 982 987 2-s2.0-33646138477 10.1161/01.HYP.0000215580. 43711.d1 (Pubitemid 44297572)
34. Brawley L., Torrens C., Anthony F. W., Itoh S., Wheeler T., Jackson A. A., Clough G. F., Poston L., Hanson M. A., Glycine rectifies vascular dysfunction induced by dietary protein imbalance during pregnancy. Journal of Physiology 2004 554 part 2 497 504 2-s2.0-0842301565 10.1113/jphysiol.2003. 052068 (Pubitemid 38181358)
35. Trayhurn P., Wood I. S., Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 2004 92 3 347 355 2-s2.0-6944237757 10.1079/BJN20041213 (Pubitemid 40277057)
36. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Walsh K., Obesity, adiponectin and vascular inflammatory disease. Current Opinion in Lipidology 2003 14 6 561 566 2-s2.0-0347334429 10.1097/00041433-200312000-00003 (Pubitemid 41623184)
37. Gualillo O., González-Juanatey J. R., Lago F., The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends in Cardiovascular Medicine 2007 17 8 275 283 2-s2.0-36049006424 10.1016/j.tcm.2007.09.005 (Pubitemid 350087698)
38. Bahia L., Aguiar L. G., Villela N., Bottino D., Godoy-Matos A. F., Geloneze B., Tambascia M., Bouskelaa E., Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics 2006 61 5 433 440 2-s2.0-33750389157 10.1590/S1807-59322006000500010 (Pubitemid 44639403)
39. Lee J. M., Kim S. R., Yoo S. J., Hong O. K., Son H. S., Chang S.-A., The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. Journal of International Medical Research 2009 37 6 1803 1812 2-s2.0-74949113508 10.1177/ 147323000903700616
40. Sell H., Dietze-Schroeder D., Kaiser U., Eckel J., Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 2006 147 5 2458 2467 2-s2.0-33645888426 10.1210/en.2005-0969
41. Lamers D., Famulla S., Wronkowitz N., Hartwig S., Lehr S., Ouwens D. M., Eckardt K., Kaufman J. M., Ryden M., Müller S., Hanisch F.-G., Ruige J., Arner P., Sell H., Eckel J., Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 2011 60 7 1917 1925 2-s2.0-80052096595 10.2337/db10-1707
42. Wei Z., Peterson J. M., Lei X., Cebotaru L., Wolfgang M. J., Baldeviano G. C., Wong G. W., C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes. The Journal of Biological Chemistry 2012 287 13 10301 10315 2-s2.0-84858953557 10.1074/jbc.M111.303651
43. Kern P. A., Ranganathan S., Li C., Wood L., Ranganathan G., Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American Journal of Physiology: Endocrinology and Metabolism 2001 280 5 E745 E751 2-s2.0-0035023128
44. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
45. Lumeng C. N., Bodzin J. L., Saltiel A. R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation 2007 117 1 175 184 2-s2.0-33846026712 10.1172/JCI29881 (Pubitemid 46048464)
46. Salans L. B., Cushman S. W., Weismann R. E., Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. Journal of Clinical Investigation 1973 52 4 929 941 2-s2.0-0015610779 10.1172/JCI107258
47. Sun K., Kusminski C. M., Scherer P. E., Adipose tissue remodeling and obesity. Journal of Clinical Investigation 2011 121 6 2094 2101 2-s2.0-79957916782 10.1172/JCI45887
48. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- α: direct role in obesity-linked insulin resistance. Science 1993 259 5091 87 91 2-s2.0-0027459878 10.1126/science. 7678183 (Pubitemid 23036092)
49. Skurk T., Alberti-Huber C., Herder C., Hauner H., Relationship between adipocyte size and adipokine expression and secretion. Journal of Clinical Endocrinology and Metabolism 2007 92 3 1023 1033 2-s2.0-33947502786 10.1210/jc.2006-1055 (Pubitemid 46465679)
50. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003 112 12 1821 1830 2-s2.0-9144223683 10.1172/JCI200319451 (Pubitemid 38063705)
51. Gnacińska M., Małgorzewicz S., Łysiak- Szydłowska W., Sworczak K., The serum profile of adipokines in overweight patients with metabolic syndrome. Endokrynologia Polska 2010 61 1 36 41 2-s2.0-77950547232
52. Maury E., Ehala-Aleksejev K., Guiot Y., Detry R., Vandenhooft A., Brichard S. M., Adipokines oversecreted by omental adipose tissue in human obesity. American Journal of Physiology: Endocrinology and Metabolism 2007 293 3 E656 E665 2-s2.0-34548448415 10.1152/ajpendo.00127.2007 (Pubitemid 47358976)
53. Hosogai N., Fukuhara A., Oshima K., Miyata Y., Tanaka S., Segawa K., Furukawa S., Tochino Y., Komuro R., Matsuda M., Shimomura I., Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007 56 4 901 911 2-s2.0-34047119110 10.2337/db06-0911 (Pubitemid 46525054)
54. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K.-I., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. Journal of Clinical Investigation 2006 116 6 1494 1505 2-s2.0-33745216724 10.1172/JCI26498
55. Elgazar-Carmon V., Rudich A., Hadad N., Levy R., Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. Journal of Lipid Research 2008 49 9 1894 1903 2-s2.0-53149119231 10.1194/jlr.M800132- JLR200
56. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., Fischer-Posovszky P., Barth T. F. E., Dragun D., Skurk T., Hauner H., Blüher M., Unger T., Wolf A.-M., Knippschild U., Hombach V., Marx N., T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 7 1304 1310 2-s2.0-46249117032 10.1161/ATVBAHA.108.165100
57. Oh D. Y., Morinaga H., Talukdar S., Bae E. J., Olefsky J. M., Increased macrophage migration into adipose tissue in obese mice. Diabetes 2012 61 2 346 354 2-s2.0-84856533216 10.2337/db11-0860
58. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., Coupaye M., Pelloux V., Hugol D., Bouillot J.-L., Bouloumié A., Barbatelli G., Cinti S., Svensson P.-A., Barsh G. S., Zucker J.-D., Basdevant A., Langin D., Clément K., Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005 54 8 2277 2286 2-s2.0-23644450775 10.2337/diabetes.54.8.2277 (Pubitemid 41134253)
59. Clément K., Viguerie N., Poitou C., Carette C., Pelloux V., Curat C. A., Sicard A., Rome S., Benis A., Zucker J.-D., Vidal H., Laville M., Barsh G. S., Basdevant A., Stich V., Cancello R., Langin D., Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB Journal 2004 18 14 1657 1669 2-s2.0-7744226149 10.1096/fj.04-2204com (Pubitemid 39463705)
60. Aron-Wisnewsky J., Tordjman J., Poitou C., Darakhshan F., Hugol D., Basdevant A., Aissat A., Guerre-Millo M., Clément K., Human adipose tissue macrophages: M1 and M2 cell surface markers in subcutaneous and omental depots and after weight loss. Journal of Clinical Endocrinology and Metabolism 2009 94 11 4619 4623 2-s2.0-70449113184 10.1210/jc.2009-0925
61. Tarry-Adkins J. L., Ozanne S. E., Mechanisms of early life programming: current knowledge and future directions. American Journal of Clinical Nutrition 2011 94 supplement 6 1765S 1771S 2-s2.0-81255202983 10.3945/ajcn.110.000620
62. Stienstra R., van Diepen J. A., Tack C. J., Zaki M. H., van de Veerdonk F. L., Perera D., Neale G. A., Hooiveld G. J., Hijmans A., Vroegrijk I., van den Berg S., Romijn J., Rensen P. C. N., Joosten L. A. B., Netea M. G., Kanneganti T.-D., Inflammasome is a central player in the induction of obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2011 108 37 15324 15329 2-s2.0-80053087484 10.1073/pnas.1100255108
63. Barak Y., Nelson M. C., Ong E. S., Jones Y. Z., Ruiz-Lozano P., Chien K. R., Koder A., Evans R. M., PPAR γ is required for placental, cardiac, and adipose tissue development. Molecular Cell 1999 4 4 585 595 2-s2.0-0033213637 10.1016/S1097-2765(00)80209-9 (Pubitemid 29531138)
64. Yan X., Zhu M. J., Xu W., Tong J. F., Ford S. P., Nathanielsz P. W., Du M., Up-regulation of toll-like receptor 4/nuclear factor- κ B signaling is associated with enhanced adipogenesis and insulin resistance in fetal skeletal muscle of obese sheep at late gestation. Endocrinology 2010 151 1 380 387 2-s2.0-73649134358 10.1210/en.2009-0849
65. Larsen G. L., Henson P. M., Mediators of inflammation. Annual Review of Immunology 1983 1 335 359 2-s2.0-0020976095
66. Howie G. J., Sloboda D. M., Reynolds C. M., Vickers M. H., Timing of maternal exposure to a high fat diet and development of obesity and hyperinsulinemia in male rat offspring: same metabolic phenotype, different developmental pathways? Journal of Nutrition and Metabolism 2013 2013 11 517384 10.1155/2013/517384
67. Li M., Reynolds C. M., Sloboda D. M., Gray C., Vickers M. H., Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity. PLoS ONE 2013 8 10 e76961
68. Dandona P., Aljada A., Bandyopadhyay A., Inflammation: the link between insulin resistance, obesity and diabetes. Trends in Immunology 2004 25 1 4 7 2-s2.0-0348222671 10.1016/j.it.2003.10.013 (Pubitemid 38032801)
69. Onore C. E., Schwartzer J. J., Careaga M., Berman R. F., Ashwood P., Maternal immune activation leads to activated inflammatory macrophages in offspring. Brain, Behavior, and Immunity 2014 38 220 226 v
70. Kirsten T. B., Lippi L. L., Bevilacqua E., Bernardi M. M., LPS exposure increases maternal corticosterone levels, causes placental injury and increases IL-1Beta levels in adult rat offspring: relevance to autism. PLoS ONE 2013 8 12 e82244
71. Schaiff W. T., Knapp F. F. Jr., Barak Y., Biron-Shental T., Nelson D. M., Sadovsky Y., Ligand-activated peroxisome proliferator activated receptor γ alters placental morphology and placental fatty acid uptake in mice. Endocrinology 2007 148 8 3625 3634 2-s2.0-34547121969 10.1210/en.2007-0211 (Pubitemid 47105868)
72. Kitajima M., Oka S., Yasuhi I., Fukuda M., Rii Y., Ishimaru T., Maternal serum triglyceride at 24-32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstetrics and Gynecology 2001 97 5, part 1 776 780 2-s2.0-0035347149 10.1016/S0029-7844(01)01328-X
73. Zhu M. J., Du M., Nathanielsz P. W., Ford S. P., Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta 2010 31 5 387 391 2-s2.0-77951974181 10.1016/j.placenta.2010.02.002
74. Chechi K., Cheema S. K., Maternal diet rich in saturated fats has deleterious effects on plasma lipids of mice. Experimental and Clinical Cardiology 2006 11 2 129 135 2-s2.0-33745775710 (Pubitemid 44018293)
75. Howie G. J., Sloboda D. M., Kamal T., Vickers M. H., Maternal nutritional history predicts obesity in adult offspring independent of postnatal diet. Journal of Physiology 2009 587 part 4 905 915 2-s2.0-60349113479 10.1113/jphysiol.2008.163477
76. Boney C. M., Verma A., Tucker R., Vohr B. R., Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005 115 3 e290 e296 2-s2.0-20344382306 10.1542/peds.2004-1808 (Pubitemid 43373011)
77. Harder T., Rodekamp E., Schellong K., Dudenhausen J. W., Plagemann A., Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. American Journal of Epidemiology 2007 165 8 849 857 2-s2.0-34047225872 10.1093/aje/kwk071 (Pubitemid 46536657)
78. Radulescu L., Munteanu O., Popa F., Cirstoiu M., The implications and consequences of maternal obesity on fetal intrauterine growth restriction. Journal of Medicine and Life 2013 6 3 292 298
79. Luzzo K. M., Wang Q., Purcell S. H., Chi M., Jimenez P. T., Grindler N., Schedl T., Moley K. H., High fat diet induced developmental defects in the mouse: oocyte meiotic aneuploidy and fetal growth retardation/brain defects. PLoS ONE 2012 7 11 e49217 10.1371/journal.pone.0049217
80. Bilbo S. D., Tsang V., Enduring consequences of maternal obesity for brain inflammation and behavior of offspring. FASEB Journal 2010 24 6 2104 2115 2-s2.0-77953521826 10.1096/fj.09-144014
81. Yan X., Huang Y., Wang H., Du M., Hess B. W., Ford S. P., Nathanielsz P. W., Zhu M.-J., Maternal obesity induces sustained inflammation in both fetal and offspring large intestine of sheep. Inflammatory Bowel Diseases 2011 17 7 1513 1522 2-s2.0-79751519983 10.1002/ibd.21539
82. Ramsay J. E., Ferrell W. R., Crawford L., Wallace A. M., Greer I. A., Sattar N., Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. Journal of Clinical Endocrinology and Metabolism 2002 87 9 4231 4237 2-s2.0-0036739961 10.1210/jc.2002-020311
83. Han J., Xu J., Epstein P. N., Liu Y. Q., Long-term effect of maternal obesity on pancreatic beta cells of offspring: reduced beta cell adaptation to high glucose and high-fat diet challenges in adult female mouse offspring. Diabetologia 2005 48 9 1810 1818 2-s2.0-24944475639 10.1007/s00125-005-1854-8 (Pubitemid 41317835)
84. Li M., Sloboda D. M., Vickers M. H., Maternal obesity and developmental programming of metabolic disorders in offspring: evidence from animal models. Experimental Diabetes Research 2011 2011 9 2-s2.0-81555201122 10.1155/2011/592408 592408
85. Ailhaud G., Grimaldi P., Négrel R., Cellular and molecular aspects of adipose tissue development. Annual Review of Nutrition 1992 12 207 233 2-s2.0-0026635508 10.1146/annurev.nu.12.070192.001231
86. Spalding K. L., Arner E., Westermark P. O., Bernard S., Buchholz B. A., Bergmann O., Blomqvist L., Hoffstedt J., Näslund E., Britton T., Concha H., Hassan M., Rydén M., Frisén J., Arner P., Dynamics of fat cell turnover in humans. Nature 2008 453 7196 783 787 2-s2.0-44849132591 10.1038/nature06902 (Pubitemid 351793777)
87. Muhlhausler B. S., Duffield J. A., McMillen I. C., Increased maternal nutrition stimulates peroxisome proliferator activated receptor- γ adiponectin, and leptin messenger ribonucleic acid expression in adipose tissue before birth. Endocrinology 2007 148 2 878 885 2-s2.0-33846425019 10.1210/en.2006-1115 (Pubitemid 46143187)
88. Murabayashi N., Sugiyama T., Zhang L., Kamimoto Y., Umekawa T., Ma N., Sagawa N., Maternal high-fat diets cause insulin resistance through inflammatory changes in fetal adipose tissue. European Journal of Obstetrics & Gynecology and Reproductive Biology 2013 169 1 39 44 10.1016/j.ejogrb.2013.02. 003
89. Stewart M. S., Heerwagen M. J., Friedman J. E., Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the "first hit" Clinical Obstetrics and Gynecology 2013 56 3 577 590 10.1097/GRF.0b013e3182a09760
90. Symonds M. E., Mostyn A., Pearce S., Budge H., Stephenson T., Endocrine and nutritional regulation of fetal adipose tissue development. Journal of Endocrinology 2003 179 3 293 299 2-s2.0-0346656883 10.1677/joe.0.1790293 (Pubitemid 38072082)
91. Oben J. A., Mouralidarane A., Samuelsson A.-M., Matthews P. J., Morgan M. L., Mckee C., Soeda J., Fernandez-Twinn D. S., Martin-Gronert M. S., Ozanne S. E., Sigala B., Novelli M., Poston L., Taylor P. D., Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. Journal of Hepatology 2010 52 6 913 920 2-s2.0-77952420159 10.1016/j.jhep.2009.12.042
92. Pruis M. G., Lendvai A., Bloks V. W., Zwier M. V., Baller J. F., de Bruin A., Groen A. K., Plosch T., Maternal western diet primes non-alcoholic fatty liver disease in adult mouse offspring. Acta Physiologica 2014 210 1 215 227 10.1111/apha.12197
93. Younossi Z. M., Stepanova M., Afendy M., Fang Y., Younossi Y., Mir H., Srishord M., Changes in the prevalence of the most common causes of chronic liver diseases in the united states from 1988 to 2008. Clinical Gastroenterology and Hepatology 2011 9 6 524.e1 530.e1 2-s2.0-79957449923 10.1016/j.cgh.2011.03. 020
94. Coulon S., Francque S., Colle I., Verrijken A., Blomme B., Heindryckx F., de Munter S., Prawitt J., Caron S., Staels B., van Vlierberghe H., van Gaal L., Geerts A., Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. Cytokine 2012 59 2 442 449 10.1016/j.cyto.2012.05.001
95. Nigam P., Bhatt S. P., Misra A., Vaidya M., Dasgupta J., Chadha D. S., Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India. PLoS ONE 2013 8 1 e49286
96. Park E. J., Lee J. H., Yu G.-Y., He G., Ali S. R., Holzer R. G., Österreicher C. H., Takahashi H., Karin M., Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010 140 2 197 208 2-s2.0-74549167737 10.1016/j.cell.2009.12. 052
97. Ashino N. G., Saito K. N., Souza F. D., Nakutz F. S., Roman E. A., Velloso L. A., Torsoni A. S., Torsoni M. A., Maternal high-fat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver. The Journal of Nutritional Biochemistry 2012 23 4 341 348 2-s2.0-84858289329 10.1016/j.jnutbio.2010.12.011
98. Gregorio B. M., Souza-Mello V., Carvalho J. J., Mandarim-De-Lacerda C. A., Aguila M. B., Maternal high-fat intake predisposes nonalcoholic fatty liver disease in C57BL/6 offspring. American Journal of Obstetrics and Gynecology 2010 203 5 495.e1 495.e8 2-s2.0-78149285063 10.1016/j.ajog.2010.06.042
99. Fink L. N., Costford S. R., Lee Y. S., Jensen T. E., Bilan P. J., Oberbach A., Bluher M., Olefsky J. M., Sams A., Klip A., Pro-Inflammatory macrophages increase in skeletal muscle of high fat-fed mice and correlate with metabolic risk markers in humans. Obesity 2014 22 3 747 757 10.1002/oby.20615
100. Tishinsky J. M., de Boer A. A., Dyck D. J., Robinson L. E., Modulation of visceral fat adipokine secretion by dietary fatty acids and ensuing changes in skeletal muscle inflammation. Applied Physiology Nutrition and Metabolism 2014 39 1 28 37 10.1139/apnm-2013-0135
101. Wei Y., Chen K., Whaley-Connell A. T., Stump C. S., Ibdah J. A., Sowers J. R., Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. American Journal of Physiology: Regulatory Integrative and Comparative Physiology 2008 294 3 R673 R680 2-s2.0-40449086344 10.1152/ajpregu.00561.2007 (Pubitemid 351346942)
102. Zoico E., Rossi A., di Francesco V., Sepe A., Olioso D., Pizzini F., Fantin F., Bosello O., Cominacini L., Harris T. B., Zamboni M., Adipose tissue infiltration in skeletal muscle of healthy elderly men: relationships with body composition, insulin resistance, and inflammation at the systemic and tissue level. Journals of Gerontology A: Biological Sciences and Medical Sciences 2010 65 3 295 299 2-s2.0-77949524652 10.1093/gerona/glp155
103. Nissen P. M., Danielsen V. O., Jorgensen P. F., Oksbjerg N., Increased maternal nutrition of sows has no beneficial effects on muscle fiber number or postnatal growth and has no impact on the meat quality of the offspring. Journal of Animal Science 2003 81 12 3018 3027 2-s2.0-2142768317 (Pubitemid 38571581)
104. Zhu M. J., Ford S. P., Means W. J., Hess B. W., Nathanielsz P. W., Du M., Maternal nutrient restriction affects properties of skeletal muscle in offspring. Journal of Physiology 2006 575 part 1 241 250 2-s2.0-33746833563 10.1113/jphysiol.2006.112110 (Pubitemid 44178141)
105. Aguiari P., Leo S., Zavan B., Vindigni V., Rimessi A., Bianchi K., Franzin C., Cortivo R., Rossato M., Vettor R., Abatangelo G., Pozzan T., Pinton P., Rizzuto R., High glucose induces adipogenic differentiation of muscle-derived stem cells. Proceedings of the National Academy of Sciences of the United States of America 2008 105 4 1226 1231 2-s2.0-39549121054 10.1073/pnas.0711402105 (Pubitemid 351397035)
106. Bayol S. A., Simbi B. H., Stickland N. C., A maternal cafeteria diet during gestation and lactation promotes adiposity and impairs skeletal muscle development and metabolism in rat offspring at weaning. Journal of Physiology 2005 567 part 3 951 961 2-s2.0-25844482016 10.1113/jphysiol.2005.088989 (Pubitemid 41387836)
107. Du M., Yan X., Tong J. F., Zhao J., Zhu M. J., Maternal obesity, inflammation, and fetal skeletal muscle development. Biology of Reproduction 2010 82 1 4 12 2-s2.0-77950344070 10.1095/biolreprod.109.077099
108. Calder P. C., n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. American Journal of Clinical Nutrition 2006 83 supplement 6 1505S 1519S 2-s2.0-33746830525 (Pubitemid 44713092)
109. Burdge G. C., Calder P. C., Conversion of α -linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction Nutrition Development 2005 45 5 581 597 2-s2.0-27244445146 10.1051/rnd:2005047 (Pubitemid 41511883)
110. Innis S. M., Dietary (n-3) fatty acids and brain development. Journal of Nutrition 2007 137 4 855 859 2-s2.0-34247108513 (Pubitemid 46596878)
111. Grygiel-Gorniak B., Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications-a review. Nutrition Journal 2014 13 1, article 17
112. Simopoulos A. P., The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine and Pharmacotherapy 2002 56 8 365 379 2-s2.0-0036776120 10.1016/S0753-3322(02)00253-6 (Pubitemid 35232740)
113. Hooper L., Thompson R. L., Harrison R. A., Summerbell C. D., Ness A. R., Moore H. J., Worthington H. V., Durrington P. N., Higgins J. P. T., Capps N. E., Riemersma R. A., Ebrahim S. B. J., Smith G. D., Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. British Medical Journal 2006 332 7544 752 755 2-s2.0-33645566760 10.1136/bmj.38755.366331.2F (Pubitemid 44365649)
114. Couet C., Delarue J., Ritz P., Antoine J. M., Lamisse F., Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. International Journal of Obesity and Related Metabolic Disorders 1997 21 8 637 643 10.1038/sj.ijo.0800451 (Pubitemid 27334170)
115. Kalupahana N. S., Claycombe K., Newman S. J., Stewart T., Siriwardhana N., Matthan N., Lichtenstein A. H., Moustaid-Moussa N., Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. Journal of Nutrition 2010 140 11 1915 1922 2-s2.0-78149275191 10.3945/jn.110.125732
116. Oliver E., McGillicuddy F. C., Harford K. A., Reynolds C. M., Phillips C. M., Ferguson J. F., Roche H. M., Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. The Journal of Nutritional Biochemistry 2011 23 9 1192 1200 10.1016/j.jnutbio.2011.06.014
117. Aas V., Rokling-Andersen M. H., Kase E. T., Thoresen G. H., Rustan A. C., Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells. Journal of Lipid Research 2006 47 2 366 374 2-s2.0-33244482431 10.1194/jlr.M500300-JLR200 (Pubitemid 43276922)
118. Pérez-Echarri N., Pérez-Matute P., Marcos-Gómez B., Baena M. J., Marti A., Martínez J. A., Moreno-Aliaga M. J., Differential inflammatory status in rats susceptible or resistant to diet-induced obesity:
119. Ferramosca A., Conte A., Burri L., Berge K., de Nuccio F., Giudetti A. M., Zara V., A krill oil supplemented diet suppresses hepatic steatosis in high-fat fed rats. PLoS ONE 2012 7 6 e38797
120. Draper E., Reynolds C. M., Canavan M., Mills K. H., Loscher C. E., Roche H. M., Omega-3 fatty acids attenuate dendritic cell function via NF- κ B independent of PPAR γ The Journal of Nutritional Biochemistry 2011 22 8 784 790 2-s2.0-79960329364 10.1016/j.jnutbio.2010.06.009
121. Neschen S., Morino K., Dong J., Wang-Fischer Y., Cline G. W., Romanelli A. J., Rossbacher J. C., Moore I. K., Regittnig W., Munoz D. S., Kim J. H., Shulman G. I., n-3 fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor- α -dependent manner. Diabetes 2007 56 4 1034 1041 2-s2.0-34047166373 10.2337/db06-1206 (Pubitemid 46525082)
122. Kratz M., Kuzma J. N., Hagman D. K., van Yserloo B., Matthys C. C., Callahan H. S., Weigles D. S., n3 PUFAs do not affect adipose tissue inflammation in overweight to moderately obese men and women. Journal of Nutrition 2013 143 8 1340 1347 10.3945/jn.113.174383
123. Frew L., Sugiarto N. U., Rajagopal S. P., He J., Leask R., Norman J. E., Riley S. C., Stock S. J., The effect of omega-3 polyunsaturated fatty acids on the inflammatory response of the amnion. Prostaglandins Leukot Essent Fatty Acids 2013 89 4 221 225 10.1016/j.plefa.2013.07.001
124. Kalanderian A., Abate N., Patrikeev I., Wei J., Vincent K. L., Motamedi M., Saade G. R., Bytautiene E., Pioglitazone therapy in mouse offspring exposed to maternal obesity. American Journal of Obstetrics & Gynecology 2013 208 4 308.e1 308.e7
125. Heerwagen M. J., Stewart M. S., de la Houssaye B. A., Janssen R. C., Friedman J. E., Transgenic increase in N-3/n-6 fatty acid ratio reduces maternal obesity-associated inflammation and limits adverse developmental programming in mice. PLoS ONE 2013 8 6 e67791
126. Siemann E. H., Creasy L. L., Concentration of the phytoalexin resveratrol in wine. American Journal of Enology and Viticulture 1992 43 1 49 52
127. Renaud S., de Lorgeril M., Wine, alcohol, platelets, and the French paradox for coronary heart disease. The Lancet 1992 339 8808 1523 1526 2-s2.0-0026651085 10.1016/0140-6736(92)91277-F
128. Lin S.-J., Defossez P.-A., Guarente L., Requirement of NAD and SIR2 for life-span extension by calorie restriction in saccharomyces cerevisiae. Science 2000 289 5487 2126 2128 2-s2.0-0034703217 10.1126/science.289.5487.2126
129. Frémont L., Minireview: biological effects of resveratrol. Life Sciences 2000 66 8 663 673 2-s2.0-0034645693 10.1016/S0024-3205(99)00410-5 (Pubitemid 30077860)
130. 2 receptor agonist in human platelets. American Journal of Chinese Medicine 2011 39 1 145 159 2-s2.0-78751525495 10.1142/S0192415X11008713
131. Saleh M. C., Connell B. J., Saleh T. M., Resveratrol induced neuroprotection is mediated via both estrogen receptor subtypes, ER alpha, and ER beta. Neuroscience Letters 2013 548 217 221 10.1016/j.neulet.2013.05.057
132. Howitz K. T., Bitterman K. J., Cohen H. Y., Lamming D. W., Lavu S., Wood J. G., Zipkin R. E., Chung P., Kisielewski A., Zhang L.-L., Scherer B., Sinclair D. A., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003 425 6954 191 196 2-s2.0-0141719702 10.1038/nature01960 (Pubitemid 37150899)
133. Banerjee S., Bueso-Ramos C., Aggarwal B. B., Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor- κ B, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Research 2002 62 17 4945 4954 2-s2.0-0036733776 (Pubitemid 34984418)
134. Pellegatta F., Bertelli A. A. E., Staels B., Duhem C., Fulgenzi A., Ferrero M. E., Different short- and long-term effects of resveratrol on nuclear factor- κ B phosphorylation and nuclear appearance in human endothelial cells. American Journal of Clinical Nutrition 2003 77 5 1220 1228 2-s2.0-0038474039 (Pubitemid 44858439)
135. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., de Oliveira R. M., Leid M., McBurney M. W., Guarente L., Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR- γ Nature 429 6993 771 776. Erratum in "Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR- γ " Nature, vol. 430, no. 7002, p. 921, 2004
136. Ulrich S., Loitsch S. M., Rau O., von Knethen A., Brüne B., Schubert-Zsilavecz M., Stein J. M., Peroxisome proliferator-activated receptor γ as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Research 2006 66 14 7348 7354 2-s2.0-33746931148 10.1158/0008-5472.CAN-05-2777 (Pubitemid 44197718)
137. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006 127 6 1109 1122 2-s2.0-33845399894 10.1016/j.cell.2006.11.013 (Pubitemid 44894520)
138. Zhu J., Yong W., Wu X., Yu Y., lv J., Liu C., Mao X., Zhu Y., Xu K., Han X., Liu C., Anti-inflammatory effect of resveratrol on TNF- α -induced MCP-1 expression in adipocytes. Biochemical and Biophysical Research Communications 2008 369 2 471 477 2-s2.0-40849106331 10.1016/j.bbrc.2008.02.034
139. Palsamy P., Subramanian S., Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomedicine and Pharmacotherapy 2008 62 9 598 605 2-s2.0-54049155669 10.1016/j.biopha.2008.06.037
140. Sharma S., Misra C. S., Arumugam S., Roy S., Shah V., Davis J. A., Shirumalla R. K., Ray A., Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes. Phytotherapy Research 2011 25 1 67 73 2-s2.0-78650636700 10.1002/ptr.3221
141. Baur J. A., Pearson K. J., Price N. L., Jamieson H. A., Lerin C., Kalra A., Prabhu V. V., Allard J. S., Lopez-Lluch G., Lewis K., Pistell P. J., Poosala S., Becker K. G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K. W., Spencer R. G., Lakatta E. G., Le Couteur D., Shaw R. J., Navas P., Puigserver P., Ingram D. K., de Cabo R., Sinclair D. A., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006 444 7117 337 342 2-s2.0-33751072349 10.1038/nature05354 (Pubitemid 44764104)
142. Um J.-H., Park S.-J., Kang H., Yang S., Foretz M., McBurney M. W., Kim M. K., Viollet B., Chung J. H., AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010 59 3 554 563 2-s2.0-77950348878 10.2337/db09-0482
143. Ramadori G., Gautron L., Fujikawa T., Vianna C. R., Elmquist J. K., Coppari R., Central administration of resveratrol improves diet-induced diabetes. Endocrinology 2009 150 12 5326 5333 2-s2.0-71949100263 10.1210/en.2009-0528
144. Ornoy A., Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reproductive Toxicology 2007 24 1 31 41 2-s2.0-34447268977 10.1016/j.reprotox.2007.04.004 (Pubitemid 47042350)
145. Singh C. K., Kumar A., Hitchcock D. B., Fan D., Goodwin R., Lavoie H. A., Nagarkatti P., Dipette D. J., Singh U. S., Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam. Molecular Nutrition and Food Research 2011 55 8 1186 1196 2-s2.0-79961060269 10.1002/mnfr.201000457
146. Williams L. D., Burdock G. A., Edwards J. A., Beck M., Bausch J., Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food and Chemical Toxicology 2009 47 9 2170 2182 2-s2.0-68049147267 10.1016/j.fct.2009.06.002
147. Roberts V. H., Pound L. D., Thorn S. R., Gillingham M. B., Thornburg K. L., Friedman J. E., Frias A. E., Grove K. L., Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates. FASEB Journal 2014 10.1096/fj.13-245472
148. Poudel R., Stanley J. L., Rueda-Clausen C. F., Andersson I. J., Sibley C. P., Davidge S. T., Baker P. N., Effects of resveratrol in pregnancy using murine models with reduced blood supply to the uterus. PLoS ONE 2013 8 5 e64401 10.1371/journal.pone.0064401
149. Dolinsky V. W., Rueda-Clausen C. F., Morton J. S., Davidge S. T., Dyck J. R. B., Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted. Diabetes 2011 60 9 2274 2284 2-s2.0-80052870161 10.2337/db11-0374
150. Singh S., Khar A., Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anti-Cancer Agents in Medicinal Chemistry 2006 6 3 259 270 2-s2.0-33744490370 10.2174/187152006776930918 (Pubitemid 43796643)
151. Joe B., Vijaykumar M., Lokesh B. R., Biological properties of curcumin-cellular and molecular mechanisms of action. Critical Reviews in Food Science and Nutrition 2004 44 2 97 111 2-s2.0-2142784187 10.1080/ 10408690490424702 (Pubitemid 38552286)
152. Singh S., Aggarwal B. B., Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. The Journal of Biological Chemistry 1995 270 42 24995 25000 10.1074/jbc.270.42.24995
153. Jobin C., Bradham C. A., Russo M. P., Juma B., Narula A. S., Brenner D. A., Sartor R. B., Curcumin blocks cytokine-mediated NF- κ B activation and proinflammatory gene expression by inhibiting inhibitory factor I- κ B kinase activity. Journal of Immunology 1999 163 6 3474 3483 2-s2.0-0033568674 (Pubitemid 29431852)
154. Jacob A., Wu R., Zhou M., Wang P., Mechanism of the anti-inflammatory effect of curcumin: PPAR- γ activation. PPAR Research 2007 2007 5 2-s2.0-38649124882 10.1155/2007/89369 89369 (Pubitemid 351171859)
155. Yeh C.-H., Chen T.-P., Wu Y.-C., Lin Y.-M., Lin P. J., Inhibition of NF κ B activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion. Journal of Surgical Research 2005 125 1 109 116 2-s2.0-17144382445 10.1016/j.jss.2004.11.009 (Pubitemid 40523784)
156. Avasarala S., Zhang F., Liu G., Wang R., London S. D., London L., Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome. PLoS ONE 2013 8 2 e57285
157. Holt P. R., Katz S., Kirshoff R., Curcumin therapy in inflammatory bowel disease: a pilot study. Digestive Diseases and Sciences 2005 50 11 2191 2193 2-s2.0-27144456477 10.1007/s10620-005-3032-8 (Pubitemid 41504112)
158. Weisberg S. P., Leibel R., Tortoriello D. V., Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 2008 149 7 3549 3558 2-s2.0-46349088791 10.1210/en.2008-0262 (Pubitemid 351919581)
159. Shao W., Yu Z., Chiang Y., Yang Y., Chai T., Foltz W., Lu H., Fantus I. G., Jin T., Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS ONE 2012 7 1 2-s2.0-84855503887 10.1371/journal.pone.0028784 e28784
160. Chen A.-L., Hsu C.-H., Lin J.-K., Hsu M.-M., Ho Y.-F., She T.-S., Ko J.-Y., Lin J.-T., Lin B.-R., Wu M.-S., Yu H.-S., Jee S.-H., Chen G.-S., Chen T.-M., Chen C.-A., Lai M.-K., Pu Y.-S., Pan M.-H., Wang Y.-J., Tsai C.-C., Hsieh C.-Y., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research 2001 21 4 2895 2900 2-s2.0-0035174504 (Pubitemid 33051148)
161. Chainani-Wu N., Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). Journal of Alternative and Complementary Medicine 2003 9 1 161 168 2-s2.0-0037291286 10.1089/107555303321223035 (Pubitemid 36297021)
162. Lao C. D., Ruffin M. T. IV, Normolle D., Heath D. D., Murray S. I., Bailey J. M., Boggs M. E., Crowell J., Rock C. L., Brenner D. E., Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine 2006 6, article 10 2-s2.0-33645648062 10.1186/1472-6882-6-10
163. Ganiger S., Malleshappa H. N., Krishnappa H., Rajashekhar G., Rao V. R., Sullivan F., A two generation reproductive toxicity study with curcumin, turmeric yellow, in Wistar rats. Food and Chemical Toxicology 2007 45 1 64 69 2-s2.0-33751346603 10.1016/j.fct.2006.07.016 (Pubitemid 44803075)
164. Huang F. J., Lan K. C., Kang H. Y., Liu Y. C., Hsuuw Y. D., Chan W. H., Huang K. E., Effect of curcumin on in vitro early post-implantation stages of mouse embryo development. European Journal of Obstetrics & Gynecology and Reproductive Biology 2013 166 1 47 51 10.1016/j.ejogrb.2012.09.010
165. Murphy C. J., Tang H., van Kirk E. A., Shen Y., Murdoch W. J., Reproductive effects of a pegylated curcumin. Reproductive Toxicology 2012 34 1 120 124 10.1016/j.reprotox.2012.04.005
166. Tiwari V., Chopra K., Attenuation of oxidative stress, neuroinflammation, and apoptosis by curcumin prevents cognitive deficits in rats postnatally exposed to ethanol. Psychopharmacology 2012 224 4 519 535 10.1007/s00213-012- 2779-9
167. Wang N. P., Wang Z. F., Tootle S., Philip T., Zhao Z. Q., Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction. British Journal of Pharmacology 2012 167 7 1550 1562 10.1111/j.1476-5381.2012.02109.x
168. Sakurai R., Li Y., Torday J. S., Rehan V. K., Curcumin augments lung maturation, preventing neonatal lung injury by inhibiting TGF- β signaling. American Journal of Physiology: Lung Cellular and Molecular Physiology 2011 301 5 L721 L730 2-s2.0-80055108237 10.1152/ajplung.00076.2011
169. Lourenço R., Camilo M. E., Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutricion Hospitalaria 2002 17 6 262 270 2-s2.0-0036877738 (Pubitemid 44616128)
170. Yamori Y., Taguchi T., Hamada A., Kunimasa K., Mori H., Mori M., Taurine in health and diseases: consistent evidence from experimental and epidemiological studies. Journal of Biomedical Science 2010 17 supplement 1, article S6 2-s2.0-77956027828 10.1186/1423-0127-17-S1-S6
171. Huxtable R. J., Physiological actions of taurine. Physiological Reviews 1992 72 1 101 164 2-s2.0-0026595620
172. Barua M., Liu Y., Quinn M. R., Taurine chloramine inhibits inducible nitric oxide synthase and TNF- α gene expression in activated alveolar macrophages: decreased NF- κ B activation and I κ B kinase activity. Journal of Immunology 2001 167 4 2275 2281 2-s2.0-0035881265 10.4049/jimmunol.167.4.2275 (Pubitemid 32747540)
173. Sun M., Zhao Y. M., Gu Y., Xu C., Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-kappa B. Amino Acids 2012 42 5 1735 1747 10.1007/s00726-011-0885-3
174. Schuller-Levis G. B., Park E., Taurine and its chloramine: modulators of immunity. Neurochemical Research 2004 29 1 117 126 2-s2.0-0842279569 10.1023/B:NERE.0000010440.37629.17 (Pubitemid 38181705)
175. Rosa F. T., Freitas E. C., Deminice R., Jordao A. A., Marchini J. S., Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study. European Journal of Nutrition 2014 53 3 823 830 10.1007/s00394-013-0586-7
176. Lin S., Hirai S., Yamaguchi Y., Goto T., Takahashi N., Tani F., Mutoh C., Sakurai T., Murakami S., Yu R., Kawada T., Taurine improves obesity-induced inflammatory responses and modulates the unbalanced phenotype of adipose tissue macrophages. Molecular Nutrition & Food Research 2013 57 12 2155 2165 10.1002/mnfr.201300150
177. Boujendar S., Reusens B., Merezak S., Ahn M.-T., Arany E., Hill D., Remacle C., Taurine supplementation to a low protein diet during foetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets. Diabetologia 2002 45 6 856 866 2-s2.0-0036596396 10.1007/s00125-002-0833-6
178. Reusens B., Sparre T., Kalbe L., Bouckenooghe T., Theys N., Kruhøffer M., Ørntoft T. F., Nerup J., Remacle C., The intrauterine metabolic environment modulates the gene expression pattern in fetal rat islets: prevention by maternal taurine supplementation. Diabetologia 2008 51 5 836 845 2-s2.0-41849120416 10.1007/s00125-008-0956-5
179. Mortensen O. H., Olsen H. L., Frandsen L., Nielsen P. E., Nielsen F. C., Grunnet N., Quistorff B., Gestational protein restriction in mice has pronounced effects on gene expression in newborn offspring's liver and skeletal muscle; protective effect of taurine. Pediatric Research 2010 67 1 47 53 2-s2.0-73449129321 10.1203/PDR.0b013e3181c4735c
180. Jaenisch R., Bird A., Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genetics 2003 33 245 254 2-s2.0-0037372003 10.1038/ng1089 (Pubitemid 36278835)
181. Gemma C., Sookoian S., Alvarĩas J., García S. I., Quintana L., Kanevsky D., González C. D., Pirola C. J., Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns. Obesity 2009 17 5 1032 1039 2-s2.0-67349133607 10.1038/oby.2008.605
182. Yang Q. Y., Liang J. F., Rogers C. J., Zhao J. X., Zhu M. J., Du M., Maternal obesity induces epigenetic modifications to facilitate Zfp423 expression and enhance adipogenic differentiation in fetal mice. Diabetes 2013 62 11 3727 3735 10.2337/db13-0433
183. Ding Y., Li J., Liu S., Zhang L., Xiao H., Li J., Chen H., Petersen R. B., Huang K., Zheng L., DNA hypomethylation of inflammation-associated genes in adipose tissue of female mice after multigenerational high fat diet feeding. International Journal of Obesity 2014 38 2 198 204 10.1038/ijo.2013.98
184. Carlin J., George R., Reyes T. M., Methyl donor supplementation blocks the adverse effects of maternal high fat diet on offspring physiology. PLoS ONE 2013 8 5 e63549
185. Cordero P., Milagro F. I., Campion J., Martinez J. A., Maternal methyl donors supplementation during lactation prevents the hyperhomocysteinemia induced by a high-fat-sucrose intake by dams. International Journal of Molecular Sciences 2013 14 12 24422 24437 10.3390/ijms141224422
186. Yang X., Wang X., Liu D., Yu L., Xue B., Shi H., Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b. Molecular Endocrinology 2014 28 4 565 574 10.1210/me.2013-1293